Today's Low | Today's High | |
---|---|---|
187.50 187.25 |
| 199.70 200.80 |
52 Week Low | 52 Week High | |
---|---|---|
92.05 (04-Jun-2024) 91.85 (04-Jun-2024) |
| 240.70 (01-Oct-2024) 240.90 (01-Oct-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
3 | 527 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 3,158 |
Ask Price | Quantity |
---|---|
192.65 | 527.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 527 |
Market Cap: | ₹48.26 Cr |
PE Ratio (TTM): | 285.44 |
PB Ratio: | 4.49 |
Industry P/E: | 156.02 |
Debt to Equity: | - |
ROE: | 1.57 |
EPS (TTM): | 0.69 |
Book Value: | 0.00 |
Face Value: | 2.00 |
Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | |
---|---|---|---|---|---|
Revenue | 1,841.00 Cr | 5.07 Cr | 24.31 Cr | 236.40 Cr | 40.42 Cr |
Profit | 307.00 Cr | 1.17 Cr | -1.22 Cr | 2.33 Cr | -6.80 Cr |
Expense | 1,470.00 Cr | 4.06 Cr | 25.63 Cr | 268.94 Cr | 52.90 Cr |
Comprehensive income | 307.00 Cr | 1.17 Cr | -1.21 Cr | 2.19 Cr | -6.80 Cr |
EPS | 2.37 | 1.12 | -0.72 | 0.01 | -0.27 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Sequent Scientific Limited | Mar, 2016 Sep, 1990 | Pharmaceuticals Pharmaceuticals | SEQUENT SEQUENT |
Promoters | |
---|---|
52.79% |
Public | |
---|---|
46.82% |
Shares held by Employee Trusts | |
---|---|
0.39% |
Promoters | |
---|---|
52.79% |
Public | |
---|---|
46.82% |
Shares held by Employee Trusts | |
---|---|
0.39% |
Promoters | |
---|---|
52.79% |
Public | |
---|---|
46.82% |
Shares held by Employee Trusts | |
---|---|
0.39% |
Promoters | |
---|---|
52.79% |
Public | |
---|---|
46.82% |
Shares held by Employee Trusts | |
---|---|
0.39% |
Promoters | |
---|---|
52.79% |
Public | |
---|---|
46.82% |
Shares held by Employee Trusts | |
---|---|
0.39% |
Today's stock performance witnessed a fluctuation from a minimum of 187.50 on the NSE (National Stock Exchange) to a maximum of 199.70. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 187.25 to a high of 200.80.
The stock's performance over the past 52 weeks reveals a low of 92.05 (occurred on 04-Jun-2024) and a high of 240.70 (achieved on 01-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 91.85 (on 04-Jun-2024), and the 52-week high is 240.90 (on 01-Oct-2024).
The stock's performance over the past 52 weeks reveals a low of 92.05 (occurred on 04-Jun-2024) and a high of 240.70 (achieved on 01-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 91.85 (on 04-Jun-2024), and the 52-week high is 240.90 (on 01-Oct-2024).
The total volume is 3, and the total traded value is 5.58 (₹ Lakhs).
The upper circuit limit is 206.25, and the lower circuit limit is 186.60.
The market cap is ₹48.26 Cr, and the PE ratio (TTM) is 179.77.
ROE is 1.57, EPS is 0.69, book value is not available
In Jun 2023, Revenue is ₹18410000000.00, and Profit is ₹3070000000.00. In Jun 2023, Revenue is ₹50655000.00, and Profit is ₹11708000.00.
The company, Sequent Scientific Limited, was listed in Mar 2016 and belongs to the Pharmaceuticals industry. Its NSE symbol is SEQUENT.
As of latest available update, promoters hold 52.79%, the public holds 46.82%, and Employee Trusts holds 0.39.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.